New Genentech Study to Investigate Familial Alzheimer’s Progression and Response to Crenezumab
Genentech, a subsidiary of Roche, has launched a new substudy to learn more about the progression of early-onset familial Alzheimer’s disease, as part of its ongoing Alzheimer’s Prevention Initiative (API)…